G-protein-coupled receptors (GPCRs) form the largest family of receptors encoded by the human genome (around 800 genes). They transduce signals by coupling to a small number of heterotrimeric G proteins (16 genes encoding different α-subunits). Each human cell contains several GPCRs and G proteins. The structural determinants of coupling of G s to four different GPCRs have been elucidated 1-4 , but the molecular details of how the other G-protein classes couple to GPCRs are unknown. Here we present the cryoelectron microscopy structure of the serotonin 5-HT 1B receptor (5-HT 1B R) bound to the agonist donitriptan and coupled to an engineered G o heterotrimer. In this complex, 5-HT 1B R is in an active state; the intracellular domain of the receptor is in a similar conformation to that observed for the β 2 -adrenoceptor (β 2 AR) 3 or the adenosine A 2A receptor (A 2A R) 1 in complex with G s . In contrast to the complexes with G s , the gap between the receptor and the Gβsubunit in the G o -5-HT 1B R complex precludes molecular contacts, and the interface between the Gα-subunit of G o and the receptor is considerably smaller. These differences are likely to be caused by the differences in the interactions with the C terminus of the G o α-subunit. The molecular variations between the interfaces of G o and G s in complex with GPCRs may contribute substantially to both the specificity of coupling and the kinetics of signalling.
. G o is the most abundant G protein in the brain and an engineered G o , mini-G o , was developed to form a heterotrimer with the Gβ and Gγ subunits, which can bind and stabilize the agonist-activated 5-HT 1B R 10 . We expressed and purified these proteins and assembled them into a complex containing 5-HT 1B R, donitriptan, mini-G o , β 1 and γ 2 subunits (see Methods). The purified complex was vitrified on electron microscopy grids and the structure was determined by cryo-electron microscopy (cryo-EM) and single-particle analysis to an overall resolution of 3.8 Å (Extended Data Figs. 1-4, Extended Data Table 1) , with clear density for the majority of side chains and the agonist donitriptan ( Fig. 1, Extended Data Fig. 2 ). Donitriptan occupies the orthosteric binding site, and the serotonin-like moiety of the ligand binds in a region analogous to that identified for the native agonists adrenaline 18 and adenosine 19 (Fig. 1, Extended Data Fig. 5 ). Donitriptan binds 5-HT 1B R in a different mode to the ergot family of alkaloids, such as ergotamine and dihydroergotamine 15 (Fig. 1) . The donitriptan-binding site is formed by amino acid residues in transmembrane helices 3, 5, 6 and 7 (H3, H5, H6 and H7) and extends into the extracellular region to make contacts with H6, H7 and extracellular loop 2 (ECL2). Donitriptan is bound primarily by van der Waals contacts and limited polar interactions with Thr134 3.37 and Asp129 3.32 is coloured according to the subunit. The inset shows the orthosteric binding pocket in 5-HT 1B R (light blue) with donitriptan depicted as sticks (green, carbon) and its density in the cryo-EM map. The lower panel shows a superposition of ergotamine-bound 5-HT 1B R (pale grey, PDB code 4IAR) 15 and donitriptan-bound 5-HT 1B R (pale blue). Donitriptan (green, carbon) and ergotamine (orange, carbon) are depicted as sticks. Letter reSeArCH (unless otherwise noted, superscripts indicate Ballesteros-Weinstein numbering for GPCRs 20 ) , similar to the binding mode of ergotamine. However donitriptan and ergotamine bind on opposite faces of the binding pocket, and different rotamers of Phe351 7. 35 and Met337 6.58 accommodate the two ligands. The resolution at the ligand binding pocket is slightly lower than for the core of the complex and there are limitations in the interpretation of the experimental data (see Methods and Extended Data Fig. 2) .
The overall conformation of 5-HT 1B R in the cryo-EM structure is consistent with the receptor being in a fully active state. Superposition with the active states of β 2 AR 3 and A 2A R 1 shows a high degree of conservation of the cytoplasmic region of the receptors (Fig. 2 ). In addition, rotamers of key conserved amino acid residues (Pro 5.50 , Ile 3.40 , Phe 6.44 ) 8 are almost identical to those in the active-state structures, suggesting that 5-HT 1B R is also in a fully active state. The structure of a 5-HT 1B R-BRIL fusion bound to the agonist ergotamine has been determined and was suggested to be in an active intermediate state owing to the partial movement of H6 and partial rotamer changes of key amino acid residues 15 . Comparison of the G o -coupled 5-HT 1B R with the ergotamine-bound 5-HT 1B R shows an 8 Å shift of the cytoplasmic end of H6 (C α of Lys311), an inward shift of H7 and H8 by 2 Å (C α of Glu374) and changes in rotamer of Arg 3.50 , Tyr 5.58 and Tyr 7.53 ( Fig. 2 ). Of note, the conformation of the extracellular region of the receptor that forms the orthosteric binding pocket does not exhibit any marked change in conformation in the transition from the active intermediate state to the active G-protein-coupled state. This resembles the transition of the A 2A R 21 , but different to that observed in β 2 AR 3 , which has a different energy landscape 22 .
The overall architecture of 5-HT 1B R coupled to G o is similar to that of the β 2 AR-G s and A 2A R-G s complexes 1,3 , but there are critical differences in the details. The interface between 5-HT 1B R and G o consists of 9 amino acid residues from 5-HT 1B R and 13 from the α-subunit of G o . This compares with 24 residues from β 2 AR and 20 in A 2A R that make contact with 17 and 22 residues in Gα s , respectively (Fig. 3 ). The surface area of G o in contact with 5-HT 1B R is 822 Å 2 , whereas the areas of G s in contact with β 2 AR and A 2A R are 1260 Å 2 and 1135 Å 2 , respectively. All the contacts made by G o with the receptor are through residues in the α5-helix. By contrast, contacts made by Gα s to β 2 AR and A 2A R also involve regions in S1, S2-S3 and H4-S6 (Extended Data Fig. 6 ). The overall conformations of Gα s and Gα o are very similar when coupled to the receptors (Extended Data Fig. 7 ). However, alignment of the cytoplasmic regions of 5-HT 1B R, β 2 AR and A 2A R shows that the α5-helix of Gα o is positioned differently within the receptor compared to Gα s (Fig. 3 , Extended Data Fig. 7 ). There is a 9° or 11° tilt of the N-terminal end of the α5-helix away from the plane of the membrane when compared to G s coupled to β 2 AR or A 2A R, respectively 
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(the pivot point is in the region of I344-N347 in Gα o ). The different tilt angles are probably the result of the different positions of the approximately eight C-terminal amino acid residues of the α5-helices that are located within the receptor. This region contains the major determinants of specificity for different G proteins 7 . The final four amino acid residues in the α5-helix of Gα s are Y H5.23 ELL H5. 26 ; the equivalent residues in Gα o are C H5.23 GLY H5. 26 (superscripts refer to the CGN numbering system 7 ). These residues form a 'wavy hook' structure at the end of the α5-helix in Gα s . In Gα s , the π-electrons of Tyr H5.23 form extensive contacts with the positively charged Arg 3.50 , which forms the boundary between the cytoplasmic cleft where the α5-helix binds and the hydrophobic core of the receptor 21 . Similarly, in G o , Cys351 H5.23 interacts with Arg147 3.50 , although only through van der Waals interactions. Therefore, the α5-helix of both G o and G s penetrate GPCRs to the same degree. In contrast to Gα s , the single amino acid residue in Gα o that makes most contacts with the receptor is the C-terminal Tyr354 H5. 26 , the side chain of which stacks against Arg308 6.29 in 5-HT 1B R and also makes a weak polar interaction with the same residue. In Gα s , the terminal amino acid Leu394 H5.26 makes only very few contacts with β 2 AR and is disordered in the A 2A R-G s structure. In the A 2A R-mini-G s crystal structure, there are extensive contacts between Glu394 H5. 24 and three Arg residues in the H7/H8 region of the receptor 21 ; the equivalent residue in G o is Gly352 H5. 24 , which makes only minor contacts with the receptor. Although it appears from the cryo-EM structure that all the major contacts between 5-HT 1B R and Gα o are mediated by the α5-helix of Gα o , there is weak density for H5 and H6 of 5-HT 1B R that extends towards the α4 helix in Gα o (Extended Data Fig. 1 ). It is known that mutations in the α4 helix can affect coupling to 5-HT 1B R 23 , but it is unclear from the structure whether this is because direct contacts to the receptor are absent from the mutated α4 helix, or because there is a secondary effect of the mutation on the structure of Gα o .
The determinants of coupling specificity of G proteins are found predominantly at the C terminus of Gα in the α5-helix and the wavy hook. The architecture of this region is virtually identical in Gα s and Gα o , but the differences in amino acid sequence (Extended Data Figs 6, 8) result in Gα s being bulkier than Gα o in the terminal five residues (Extended Data Fig. 9 ). This may be sufficient to prevent coupling of G s to some G o -specific GPCRs as the narrower crevice in these GPCRs may exclude the bulkier C terminus of G s . Conversely, the wider crevice in G s -coupled receptors may allow coupling of G o , provided that there are suitable residues lining the crevice to form a good interface. This last caveat raises the problem of predicting G-protein-coupling specificity. Although the structure and mechanism of GPCRs are highly conserved 8, 24 , human GPCRs show considerable sequence heterogeneity; therefore, there is little or no specific amino acid conservation correlating with the subtype of G protein that a receptor couples to 25 . In addition, there is potential for different GPCR conformations 26 , which suggests that the mode of G-protein coupling could be different between different receptors. This is the case in the complex of transducin peptide and opsin 27 , in which the α5-helix is tilted by around 30° in comparison to the α5-helix of G o , even though the G proteins are in the same family. More structures need to be determined to evaluate the diversity of G-protein coupling. 
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The specific differences in packing at the C terminus of G o compared to G s have a disproportionate effect on the whole G protein owing to their amplification as a result of the different insertion angle of the α5-helix. This results in a change in the tilt of the whole G protein, which moves away from the plane of the membrane and results in a gap between the rest of the G protein and 5-HT 1B R. Therefore, there are no contacts between 5-HT 1B R and Gβ subunits, and the only contacts made to Gα are with the α5-helix. This is in marked contrast to the relatively close packing of G s to both A 2A R and β 2 AR (Fig. 4) . Given that the mechanism of GPCR 24 and G-protein activation is conserved 7 , it is likely that the small interface between 5-HT 1B R and G o is a common feature of receptor coupling with G i/o family, and will be seen in other GPCRs that are activated by diffusible ligands. A likely consequence of the small interface in the receptor-G i/o complex is that G i/o may have a faster rate of dissociation than G s in the same GPCR. The kinetics of the steps in GPCR signalling pathways are thought to have a profound effect on which particular signalling event results from agonist binding to a receptor in a specific cell type 28, 29 . A combination of structural data and kinetic analyses will be essential to unravel the complexities of this system.
Online content
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MEthodS Expression and purification of 5-HT 1B R. N-terminally truncated wild-type human 5-HT 1B R (residues 34-390) was modified to contain a C-terminal histidine tag (His 10 ) and TEV protease cleavage site 10 . The L138W 3.41 mutation was introduced to increase thermostability. Recombinant baculoviruses expressing 5-HT 1B R were prepared using the flashBAC ULTRA system (Oxford Expression Technologies). Trichoplusia ni cells (Expression Systems) were grown in suspension in ESF921 media (Expression Systems) to a density of 3 × 10 6 cells/ml, infected with 5-HT 1B R baculovirus and incubated for 48 h. Cells were harvested and membranes prepared by two ultracentrifugation steps in 20 mM HEPES pH7.5, 1 mM EDTA, 1 mM PMSF. Membranes were resuspended finally in 20 mM HEPES pH7.5, 500 mM NaCl, 5 mM MgCl 2 , 10 mM imidazole and Complete protease inhibitors (Roche) and flash frozen in liquid nitrogen and stored at −80 °C.
Membranes from 2 l of cells were solubilised with 2% n-decyl-β-d-maltopyranoside (DM) on ice for 30 min in the presence of 1 μM donitriptan hydrochloride. The sample was clarified by ultracentrifugation and loaded onto a 5 ml Ni-NTA column (Generon). The column was equilibrated and sample was loaded in buffer A (20 mM HEPES pH 7.5, 500 mM NaCl, 1 mM MgCl 2 , 50 mM imidazole, 1 μM donitriptan hydrochloride, 0.15% DM), and eluted with buffer B (20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM MgCl 2 , 300 mM imidazole, 1 μM donitriptan hydrochloride, 0.15% DM). The eluate was concentrated using a 50-kDa cut-off Amicon centrifugal ultrafiltration unit (Millipore), and exchanged into desalting buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM MgCl 2 , 1 μM donitriptan hydrochloride, 0.15% DM) using a PD10 column (GE Healthcare). Then, 2.5 mg TEV protease was added, and the sample was incubated on ice overnight. TEV protease was removed by negative purification on Ni 2+ -NTA resin. The sample was concentrated to ~1 ml and loaded onto a Superdex 200 column (GE Healthcare). Peak fractions corresponding to monomers of receptors were pooled and concentrated. A typical yield was 1-2 mg pure 5-HT 1B R per litre of culture.
Formation of a 5-HT 1B R-heterotrimeric mini-G o complex.
Purified 5-HT 1B R was mixed with a 1.2-fold molar excess of mini-G o1 β 1 γ 2 in the presence of apyrase (0.2 U/ml) and the mixture was incubated on ice overnight 10 . The sample was loaded on to a Superdex 200 column. Peak fractions containing the 5-HT 1B Rmini-G o1 β 1 γ 2 complex were pooled and concentrated to 4 mg/ml. Cryo-grid preparation and data collection. Cryo-EM grids were prepared by applying 3 μl sample (at a protein concentration of 2.2 mg/ml) on glow-discharged holey gold grids (Quantifoil Au 1.2/1.3 300 mesh). Excess sample was removed by blotting with filter paper for 3-4 s before plunge-freezing in liquid ethane using a FEI Vitrobot Mark IV at 100% humidity and 4 °C. Images were collected on a FEI Titan Krios microscope at 300 kV using a Falcon III detector in electron counting mode and a Volta phase plate. EPU software (FEI) was used for automatic data collection. Data were collected in nine independent sessions to give a total of 5,737 movies. Each micrograph was collected as 75 movie frames at a dose rate of 0.5 e − /pixel/sec (0.4 e − /Å 2 per frame) for 60 s, with a total accumulated dose of ~30 e − /Å 2 . The magnification used was 75,000×, yielding a pixel size of 1.06 Å/pixel. Data processing and model building. RELION-2.1 was used for all data processing 31 unless otherwise specified. Since data were pooled from nine independent sessions we provide here the general strategy for data collection and processing, while precise particle numbers for a representative dataset are presented in Extended Data Fig. 3 . Overall, drift, beam induced motion and dose weighting were corrected with MotionCor2 32 using 5 × 5 patches. CTF fitting and phase shift estimation were performed using Gctf v.0.1.06 33 , which yielded the characteristic pattern of phase shift accumulation over time for each position. Generally, 40 images were taken at each Volta phase plate position. Auto-picking was performed with a Gaussian blob as a template 34 which readily resulted in optimal particle picking. Particles were extracted in a box of 150 pixels (159 Å) and inputted into a one or two reference-free 2D classification (if the majority of 2D classes had nonrecognizable or low-quality features, then the selected particles belonging to quality classes were taken to a second round of 2D classification). An ab initio model was generated using 10,000 particles with RELION 2.1 35 in the first data collection and used throughout. The resulting particles after 2D classification where then used for 3D classification in both three and four classes simultaneously in order to check for consistency in 3D classification and to generate models with different numbers of particles. The models with the best defined features were selected for refinement either on their own or together with a second class from the same 3D classification (if more than one quality model was present). The particles that reached the highest resolution after gold-standard resolution estimation were saved. Particles obtained in a similar fashion from the different sessions were then merged and refined together. During refinement, the low-pass filter effect of the Wiener filter in the regularised likelihood optimisation algorithm was relaxed through the use of a regularisation parameter (T = 3). This allowed the refinement algorithm to consider higher spatial frequencies in the alignment of the individual particles. Nevertheless, both half-reconstructions were kept completely separately, and the final resolution estimate (at the post-processing stage in RELION) was based on the standard Fourier shell correlation (FSC) between the two unfiltered halfreconstructions. The final model contained 730,118 particles and reached an overall resolution of 3.78 Å with side chains visible for most of the complex (Extended Data Figs. 1, 2) . Local resolution estimates were calculated with Resmap 36 showing a core of the protein at ~3.5 Å resolution and an extracellular region of the receptor and βγ N termini at poorer resolution with the worst regions reaching ~5 Å (Extended Data Fig. 1 ). Signal subtraction of the DM micelle did not improve the quality of the map upon refinement.
Model building and refinement was carried out using the CCP-EM software suite 37 . The 5-HT 1B R-ergotamine crystal structure was used as a starting model (Protein Data Bank (PDB) accession 4IAR) 15 for receptor building. 5-HT 1B R was modelled from residue L45 to R385. Although density was present from Y38 and this region seems to adopt a similar conformation to the 5-HT 1B R crystal structure, the poor resolution in this region prompted us to leave it unmodelled. Residues R188 to V196 in the ECL2 and I339 to C344 in ICL3 were flexible with absent or very poor map density and were therefore, not modelled. For the same reason residues K241 to L304 forming the large 5-HT 1B R ICL3 loop were left unmodelled. Mini-G o was modelled from residue L5 to Y354 following native Gα o numbering. Modifications in Gα o to obtain mini-G o are as described 10 (Extended Data Fig. 7) . Although β and γ subunits were modelled using the available crystal structures, poor density was found for both N termini, with the whole of the γ subunit having poor density. For this reason the worst regions of these subunits were modelled as poly-alanine. Initial manual model building was performed in Coot 38 following a jelly-body refinement in REFMAC5 39 . Donitriptan coordinates and library were created with JLigand 40 and manually fitted into the density using sphere real space refinement in Coot. Restraints were generated with ProSMART 41 in order to maintain structural features in regions of poorer density. B factors were reset to 40 Å 2 before refinement. The model then followed cycles of manual modifications in Coot and restraint refinement in REFMAC5. The final model achieved good geometry (Extended Data Table 1 ) with validation of model performed in Coot, Molprobity 42 and EMRinger 43 . The goodness of fit of the model to the map was carried out using Phenix 44 using a global model-vs-map FSC correlation (Extended Data Fig. 2 ). Overfitting in refinement was monitored throughout using FSC work / FSC test 45 .
Note on limitations of the interpretation of density in the ligand binding pocket.
The ligand binding pocket of 5-HT 1B R is occupied by a single molecule of the agonist donitriptan. Despite the resolution varying between 3.8 Å to 4.3 Å in this region, estimated from the local resolution map (Extended Data Fig. 1 ), the density allowed modelling of the position and orientation of donitriptan and the majority of the amino acid side chains in the pocket. However, the resolution limits the accuracy of the refined coordinates and care must be taken when analysing the precise details of any potential interactions. The best resolution is towards the centre of the membrane bilayer and resolution gets worse towards the extracellular surface of the receptor. The ligand has been modelled using real space refinement, taking into account the location of nearby residues as well as using a library of restraints with allowed conformations of donitriptan. The density allowed modelling of the position and orientation of the donitriptan molecule, with the indole group buried deep in the orthosteric binding pocket and the remainder of the ligand protruding towards the extracellular surface.
Clear interpretable density is found for large aromatic groups, while density is poorer for residues with smaller side chains such as Ser334 6.55 and Ser212 5.42 . Tyr359 7.43 , Phe330 6.51 and Phe331 6.52 are positioned around the indole group at the base of the pocket and Phe351 7.35 interacts with the donitriptan aromatic moiety at the most extracellular region. Met337 6.58 is located in a region of poor density and has been modelled so that is oriented away from the pocket and interacting with the aromatic group of donitriptan. This was concluded based on interpretation of maps with different sharpening levels, but its rotamer cannot be assigned with confidence. The orientation of the primary amine on the serotonin moiety in donitriptan and the adjacent side chain of Asp129 3.32 cannot be confidently assigned owing to poor density. However, Asp129 3.32 is absolutely conserved in all the human serotonin GPCRs and forms a hydrogen bond with ergotamine in the high-resolution crystal structure of 5-HT 1B R. We have therefore modelled Asp129 3.32 in a similar rotamer to make a potential hydrogen bond with this primary amine in donitriptan, despite the lack of density for both the primary amine and the carboxyl group of Asp129 3.32 . Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data availability. All data generated or analysed during this study are included in this published article and its Supplementary Information. The cryo-EM density map has been deposited in the Electron Microscopy Data Bank under accession code EMD-4358 and the coordinates have been deposited in the Protein Data Bank under accession number 6G79. At the bottom of the figure, the final number of particles is shown. Each dataset was corrected separately for drift, beam-induced motion and radiation damage. After CTF estimation, particles were picked using a Gaussian blob and submitted to either one or two rounds of reference-free 2D classification (see Methods). A 3D classification was performed on the selected particles using an ab initio model generated from ten thousand particles. Classification was performed in parallel in three and four classes. The models with best features were refined on their own; if there were two classes of similar high quality, these were then re-refined together (the resolution of the models refers to the resolution after refinement and calculation of gold-standard FSC = 0.143). The set of particles that obtained the best map quality and resolution were saved and merged with the best particles from other datasets. A final model with 730,118 particles was refined and achieved a global resolution of 3.78 Å. 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
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